Literature DB >> 9188566

Herpes simplex virus type 1 glycoprotein K is not essential for infectious virus production in actively replicating cells but is required for efficient envelopment and translocation of infectious virions from the cytoplasm to the extracellular space.

S Jayachandra1, A Baghian, K G Kousoulas.   

Abstract

We characterized the glycoprotein K (gK)-null herpes simplex virus type 1 [HSV-1] (KOS) delta gK and compared it to the gK-null virus HSV-1 F-gKbeta (L. Hutchinson et al., J. Virol. 69:5401-5413, 1995). delta gK and F-gKbeta mutant viruses produced small plaques on Vero cell monolayers at 48 h postinfection. F-gKbeta caused extensive fusion of 143TK cells that was sensitive to melittin, a specific inhibitor of gK-induced cell fusion, while delta gK virus did not fuse 143TK cells. A recombinant plasmid containing the truncated gK gene specified by F-gKbeta failed to rescue the ICP27-null virus KOS (d27-1), while a plasmid with the delta gK deletion rescued the d27-1 virus efficiently. delta gK virus yield was approximately 100,000-fold lower in stationary cells than in actively replicating Vero cells. The plaquing efficiencies of delta gK and F-gKbeta virus stocks on VK302 cells were similar, while the plaquing efficiency of F-gKbeta virus stocks on Vero cells was reduced nearly 10,000-fold in comparison to that of delta gK virus. Mutant delta gK and F-gKbeta infectious virions accumulated within Vero and HEp-2 cells but failed to translocate to extracellular spaces. delta gK capsids accumulated in the nuclei of Vero but not HEp-2 cells. Enveloped delta gK virions were visualized in the cytoplasms of both Vero and HEp-2 cells, and viral capsids were found in the cytoplasm of HEp-2 cells within vesicles. Glycoproteins B, C, D, and H were expressed on the surface of delta gK-infected Vero cells in amounts similar to those for KOS-infected Vero cells. These results indicate that gK is involved in nucleocapsid envelopment, and more importantly in the translocation of infectious virions from the cytoplasm to the extracellular spaces, and that actively replicating cells can partially compensate for the envelopment but not for the cellular egress deficiency of the delta gK virus. Comparison of delta gK and F-gKbeta viruses suggests that the inefficient viral replication and plaquing efficiency of F-gKbeta virus in Vero cells and its syncytial phenotype in 143TK- cells are most likely due to expression of a truncated gK.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9188566      PMCID: PMC191734          DOI: 10.1128/JVI.71.7.5012-5024.1997

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Genetic evidence for two distinct transactivation functions of the herpes simplex virus alpha protein ICP27.

Authors:  S A Rice; D M Knipe
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

2.  A conserved open reading frame that overlaps the herpes simplex virus thymidine kinase gene is important for viral growth in cell culture.

Authors:  J G Jacobson; S L Martin; D M Coen
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

3.  Individual herpes simplex virus 1 glycoproteins display characteristic rates of maturation from precursor to mature form both in infected cells and in cells that constitutively express the glycoproteins.

Authors:  G Campadelli-Fiume; M T Lombardo; L Foà-Tomasi; E Avitabile; F Serafini-Cessi
Journal:  Virus Res       Date:  1988-04       Impact factor: 3.303

4.  An ICP6::lacZ insertional mutagen is used to demonstrate that the UL52 gene of herpes simplex virus type 1 is required for virus growth and DNA synthesis.

Authors:  D J Goldstein; S K Weller
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

5.  Virus-specific glycoproteins associated with the nuclear fraction of herpes simplex virus type 1-infected cells.

Authors:  T Compton; R J Courtney
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

6.  Herpes simplex virus particles are unable to traverse the secretory pathway in the mouse L-cell mutant gro29.

Authors:  B W Banfield; F Tufaro
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

7.  Glycoprotein D of herpes simplex virus encodes a domain which precludes penetration of cells expressing the glycoprotein by superinfecting herpes simplex virus.

Authors:  G Campadelli-Fiume; S Qi; E Avitabile; L Foà-Tomasi; R Brandimarti; B Roizman
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

8.  Antibody response to epitopes of chlamydial major outer membrane proteins on infectious elementary bodies and of the reduced polyacrylamide gel electrophoresis-separated form.

Authors:  A Baghian; L Shaffer; J Storz
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

9.  Effect of brefeldin A on alphaherpesvirus membrane protein glycosylation and virus egress.

Authors:  M E Whealy; J P Card; R P Meade; A K Robbins; L W Enquist
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

10.  The effect of ammonium chloride and tunicamycin on the glycoprotein content and infectivity of herpes simplex virus type 1.

Authors:  K G Kousoulas; D J Bzik; N DeLuca; S Person
Journal:  Virology       Date:  1983-03       Impact factor: 3.616

View more
  59 in total

1.  Herpes simplex virus type 1 U(L)34 gene product is required for viral envelopment.

Authors:  R J Roller; Y Zhou; R Schnetzer; J Ferguson; D DeSalvo
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Genetic analysis of the role of herpes simplex virus type 1 glycoprotein K in infectious virus production and egress.

Authors:  T P Foster; K G Kousoulas
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

3.  Primary envelopment of pseudorabies virus at the nuclear membrane requires the UL34 gene product.

Authors:  B G Klupp; H Granzow; T C Mettenleiter
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  Glycoprotein K specified by herpes simplex virus type 1 is expressed on virions as a Golgi complex-dependent glycosylated species and functions in virion entry.

Authors:  T P Foster; G V Rybachuk; K G Kousoulas
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

Review 5.  Glycoprotein K of herpes simplex virus: a transmembrane protein encoded by the UL53 gene which regulates membrane fusion.

Authors:  J Rajcáni; M Kúdelová
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

6.  Ultrastructural localization of the herpes simplex virus type 1 UL31, UL34, and US3 proteins suggests specific roles in primary envelopment and egress of nucleocapsids.

Authors:  Ashley E Reynolds; Elizabeth G Wills; Richard J Roller; Brent J Ryckman; Joel D Baines
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

7.  Coexpression of UL20p and gK inhibits cell-cell fusion mediated by herpes simplex virus glycoproteins gD, gH-gL, and wild-type gB or an endocytosis-defective gB mutant and downmodulates their cell surface expression.

Authors:  Elisa Avitabile; Giulia Lombardi; Tatiana Gianni; Miriam Capri; Gabriella Campadelli-Fiume
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

8.  Identification of an essential domain in the herpes simplex virus 1 UL34 protein that is necessary and sufficient to interact with UL31 protein.

Authors:  Li Liang; Joel D Baines
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

9.  The protein encoded by the US3 orthologue of Marek's disease virus is required for efficient de-envelopment of perinuclear virions and involved in actin stress fiber breakdown.

Authors:  Daniel Schumacher; B Karsten Tischer; Sascha Trapp; Nikolaus Osterrieder
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

10.  Binding of Herpes Simplex Virus 1 UL20 to GODZ (DHHC3) Affects Its Palmitoylation and Is Essential for Infectivity and Proper Targeting and Localization of UL20 and Glycoprotein K.

Authors:  Shaohui Wang; Kevin R Mott; Kolja Wawrowsky; Konstantin G Kousoulas; Bernhard Luscher; Homayon Ghiasi
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.